The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa® (oral octreotide) in Acromegaly Patients
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com